July 29 (Reuters) — AbbVie Inc has set aside about $2 billion to resolve thousands of lawsuits against its Allergan unit over the marketing of its opioid products, the company said on Friday. No final deal has been announced.AbbVie faces more than 3,000 lawsuits from state and local governments around the country over the drug.…
Read More